TheProfitWatch

ATNM - Actinium Pharmaceuticals, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.28 0.04 (3.13%) 0.01 (0.44%) 0.01 (0.44%) 0.0 (-0.38%) --- 0.04 (3.13%) 0.0 (0.0%) 0.0 (0.0%)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.22
Diluted EPS:
-0.22
Basic P/E:
-6.0
Diluted P/E:
-6.0
RSI(14) 1m:
33.22
VWAP:
1.32
RVol:

Events

Period Kind Movement Occurred At

Related News